Return to homepagePandemic Pact

Real-time evaluations of Covid-19 vaccination in Swedish healthcare regions based on an information platform that supports system modeling and machine learning

Grant number: 2021-05608

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $1,822,712.8

  • Funder

    TUBITAK

  • Principal Investigator

    Thomas Beautiful

  • Research Location

    Sweden

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

5 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations.

Making US public health a good idea again.

Effectiveness of the BNT162b2 mRNA Vaccine Compared with Hybrid Immunity in Populations Prioritized and Non-Prioritized for COVID-19 Vaccination in 2021-2022: A Naturalistic Case-Control Study in Sweden.

Corruption should be taken into account when considering COVID-19 vaccine allocation.

Cyberchondria, Fear of COVID-19, and Risk Perception Mediate the Association between Problematic Social Media Use and Intention to Get a COVID-19 Vaccine.